Form 4 · Filed Jun 16, 2026, 10:19 PM UTC
EWTX/Edgewise Therapeutics, Inc.
Edris Badreddin — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | A | other | 5,619 | — | — | 5,619 |
| Jun 5, 2026 | A | other | 8,188 | — | — | 8,188 |
Source: SEC EDGAR raw filing ↗ · Accession 0001786966-26-000003